Positive Inotropic Effects by Uridine Triphosphate (UTP) and Uridine Diphosphate (UDP) via P2Y2 and P2Y6 Receptors on Cardiomyocytes and Release of UTP in Man During Myocardial Infarction

The aim of this study was to examine a possible role for extracellular pyrimidines as inotropic factors for the heart. First, nucleotide plasma levels were measured to evaluate whether UTP is released in patients with coronary heart disease. Then, inotropic effects of pyrimidines were examined in isolated mouse cardiomyocytes. Finally, expression of pyrimidine-selective receptors (a subgroup of the P2 receptors) was studied in human and mouse heart, using real time polymerase chain reaction, Western blot, and immunohistochemistry. Venous plasma levels of UTP were increased (57%) in patients with myocardial infarction. In electrically stimulated cardiomyocytes the stable P2Y2/4 agonist UTPγS increased contraction by 52%, similar to β1-adrenergic stimulation with isoproterenol (65%). The P2Y6-agonist UDPβS also increased cardiomyocyte contraction (35%), an effect abolished by the P2Y6-blocker MRS2578. The phospholipase C inhibitor U73122 inhibited both the UDPβS and the UTPγS-induced inotropic effect, indicating an IP3-mediated effect via P2Y6 receptors. The P2Y14 agonist UDP-glucose was without effect. Quantification of mRNA with real time polymerase chain reaction revealed P2Y2 as the most abundant pyrimidine receptor expressed in cardiomyocytes from man. Presence of P2Y6 receptor mRNA was detected in both species and confirmed at protein level with Western blot and immunohistochemistry in man. In conclusion, UTP levels are increased in humans during myocardial infarction, giving the first evidence for UTP release in man. UTP is a cardiac inotropic factor most likely by activation of P2Y2 receptors in man. For the first time we demonstrate inotropic effects of UDP, mediated by P2Y6 receptors via an IP3-dependent pathway. Thus, the extracellular pyrimidines (UTP and UDP) could be important inotropic factors involved in the development of cardiac disease.

[1]  K. Jacobson,et al.  Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors. , 2005, Journal of molecular and cellular cardiology.

[2]  D. Erlinge,et al.  Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels , 2005, Thrombosis journal.

[3]  J. Harnek,et al.  Uridine triphosphate (UTP) is released during cardiac ischemia. , 2005, International journal of cardiology.

[4]  K. Jacobson,et al.  Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress. , 2005, Biochemical pharmacology.

[5]  K. Jacobson,et al.  Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. , 2004, Biochemical pharmacology.

[6]  G. Burnstock.  Introduction: P2 receptors. , 2004, Current topics in medicinal chemistry.

[7]  D. Erlinge,et al.  Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. , 2003, The Annals of thoracic surgery.

[8]  R. Boucher,et al.  Release of cellular UDP-glucose as a potential extracellular signaling molecule. , 2003, Molecular pharmacology.

[9]  K. Jacobson,et al.  Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium‐derived hyperpolarising factor , 2003, British journal of pharmacology.

[10]  James B Morris,et al.  UTP but not ATP causes hypertrophic growth in neonatal rat cardiomyocytes. , 2003, Journal of molecular and cellular cardiology.

[11]  D. Erlinge,et al.  P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells , 2002, Journal of cardiovascular pharmacology.

[12]  J. T. Turner,et al.  Functional P2Y2 Nucleotide Receptors Mediate Uridine 5′-Triphosphate–Induced Intimal Hyperplasia in Collared Rabbit Carotid Arteries , 2002, Circulation.

[13]  X. Pillois,et al.  Nucleotide Receptors Involved in UTP-Induced Rat Arterial Smooth Muscle Cell Migration , 2002, Circulation research.

[14]  C. Kuhn,et al.  UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. , 2002, American journal of physiology. Heart and circulatory physiology.

[15]  P. Emson,et al.  Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs. , 2001, Genomics.

[16]  D. Erlinge,et al.  Extracellular Nucleotides ATP and UTP Induce a Marked Acute Release of Tissue-type Plasminogen Activator In Vivo in Man , 2001, Thrombosis and Haemostasis.

[17]  G. Vassort.  Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium. , 2001, Physiological reviews.

[18]  E. Ragazzi,et al.  Do ATP and UTP involve cGMP in positive inotropism on rat atria? , 2001, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[19]  T. K. Harden,et al.  The stable pyrimidines UDPβS and UTPγS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery , 2000 .

[20]  T. K. Harden,et al.  Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate. , 2000, The Journal of pharmacology and experimental therapeutics.

[21]  J. Chambers,et al.  A G Protein-coupled Receptor for UDP-glucose* , 2000, The Journal of Biological Chemistry.

[22]  T. Hedner,et al.  Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. , 1999, Life sciences.

[23]  T. K. Harden,et al.  Quantitation of extracellular UTP using a sensitive enzymatic assay , 1999, British journal of pharmacology.

[24]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[25]  Marc Parmentier,et al.  Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl Cyclase* , 1997, The Journal of Biological Chemistry.

[26]  B. Liang,et al.  A novel phospholipase C- and cAMP-independent positive inotropic mechanism via a P2 purinoceptor. , 1997, American journal of physiology. Heart and circulatory physiology.

[27]  J. Boeynaems,et al.  Slow desensitization of the human P2Y6 receptor. , 1997, European journal of pharmacology.

[28]  K. Varani,et al.  P2X-purinoceptors in the heart: actions of ATP and UTP. , 1997, Life sciences.

[29]  R. Boucher,et al.  Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity. , 1997, Trends in pharmacological sciences.

[30]  W. Watt,et al.  Pharmacological and second messenger signalling selectivities of cloned P2Y receptors. , 1996, Journal of autonomic pharmacology.

[31]  W. Watt,et al.  Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. , 1996, Molecular Pharmacology.

[32]  M. Parmentier,et al.  Cloning, functional expression and tissue distribution of the human P2Y6 receptor. , 1996, Biochemical and biophysical research communications.

[33]  S. Pirotton,et al.  Pharmacological characterization of the human P2Y4 receptor. , 1996, European journal of pharmacology.

[34]  E. Ragazzi,et al.  Dual effect of ATP and UTP on rat atria: which types of receptors are involved? , 1994, Naunyn-Schmiedeberg’s Archives of Pharmacology.

[35]  D. Reis,et al.  Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. , 1993, The American journal of physiology.

[36]  B. Johansson,et al.  Effects of low temperature on contraction in papillary muscles from rabbit, rat, and hedgehog. , 1990, Cryobiology.

[37]  L. Opie,et al.  Significance of release of adenosine triphosphate and adenosine induced by hypoxia or adrenaline in perfused rat heart. , 1987, Journal of molecular and cellular cardiology.

[38]  J. L. Gordon.  Extracellular ATP: effects, sources and fate. , 1986, The Biochemical journal.

[39]  T. Forrester,et al.  Appearance of adenosine triphosphate in the coronary sinus effluent from isolated working rat heart in response to hypoxia. , 1981, The Journal of physiology.

[40]  F. W. Flitney,et al.  Inotropic responses of the frog ventricle to adenosine triphosphate and related changes in endogenous cyclic nucleotides. , 1980, The Journal of physiology.

[41]  A. Szent-Györgyi,et al.  The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart 1 , 1929, The Journal of physiology.

[42]  D. Erlinge,et al.  The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. , 2000, British Journal of Pharmacology.

[43]  G. Burnstock,et al.  Uptake and Flow-induced Release of Uridine Nucleotides from Isolated Vascular Endothelial Cells , 1995 .

[44]  V. Sharma,et al.  Mechanism of extracellular ATP‐induced increase of cytosolic Ca2+ concentration in isolated rat ventricular myocytes. , 1992, The Journal of physiology.